Results of Aelis Farma Combined General Meeting of May 24, 2023

Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, announces that all the

Related Keywords

United States ,France ,Spain ,Gewinn Nur ,Arthur Rouill ,Daelis Farma ,Vincenzo Piazza ,Magendie Neurocenter ,Anders Gersel Pedersen ,Twitter ,Linkedin ,Regulatory News ,Combined General Meeting ,Chief Executive Officer ,Lafaurie De Monbadon ,Signaling Specific ,Pier Vincenzo Piazza ,Down Syndrome ,Euronext Paris ,Universal Registration Document ,Des March ,Results ,Elis ,Sarma ,Combined ,Eneral ,Meeting ,023 ,